Zoetis (ZTS) Change in Account Payables (2014 - 2026)
Zoetis' (ZTS) quarterly Change in Account Payables came in at -$53.0 million in Q2 2026, down 657.14% year-over-year from $9.5 million in Q2 2025, and down 185.48% quarter-over-quarter from $62.0 million in Q1 2026.
Analysis
Zoetis (ZTS) Change in Account Payables (2014 - 2026) Analysis & Trends
Zoetis (ZTS) has reported Change in Account Payables for 13 consecutive years, with -$53.0 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Change in Account Payables fell 657.14% year-over-year to -$53.0 million in Q2 2026; TTM through Jun 2026 was $40.0 million, a 53.85% increase from a year earlier, with the FY2025 full-year figure at $46.0 million, up 48.39% from the prior year.
- Change in Account Payables was -$53.0 million for Q2 2026 at Zoetis, down from $62.0 million in the prior quarter.
- Over five years, Change in Account Payables peaked at $76.0 million in Q4 2025 and troughed at -$74.0 million in Q3 2023.
- A 5-year average of $3.9 million and a median of $22.0 million in 2023 frame the typical range for Change in Account Payables.
- Across the five-year window, Change in Account Payables surged 833.33% in 2025 and plunged 657.14% in 2026, its largest moves.
- Over 5 years, Change in Account Payables stood at $30.0 million in 2022, then dropped by 26.67% to $22.0 million in 2023, then advanced by 18.18% to $26.0 million in 2024, then soared by 192.31% to $76.0 million in 2025, then sank by 169.74% to -$53.0 million in 2026.
- The last three Change in Account Payables figures came in at -$53.0 million (Q2 2026), $62.0 million (Q1 2026), and $76.0 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.64 Bn | 40.44 Bn | 779.09 Mn | -6.74 Mn |
| 2 | Zoetis | 30.58 Bn | 28.90 Bn | 1.05 Bn | -53.00 Mn |
| 3 | Elanco Animal Health | 11.78 Bn | 11.25 Bn | 798.00 Mn | - |
| 4 | Phibro Animal Health | 1.49 Bn | 1.41 Bn | 134.40 Mn | -5.65 Mn |
| 5 | Immucell | 89.92 Mn | 81.06 Mn | 2.44 Mn | - |
| 6 | Zhengye Biotechnology Holding | 74.81 Mn | 67.72 Mn | - | - |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - | -109.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -53.00 Mn |
| Mar 31, 2026 | 62.00 Mn |
| Dec 31, 2025 | 76.00 Mn |
| Sep 30, 2025 | -45.00 Mn |
| Jun 30, 2025 | -7.00 Mn |
| Mar 31, 2025 | 22.00 Mn |
| Dec 31, 2024 | 26.00 Mn |
| Sep 30, 2024 | -15.00 Mn |
| Jun 30, 2024 | 23.00 Mn |
| Mar 31, 2024 | -3.00 Mn |
| Dec 31, 2023 | 22.00 Mn |
| Sep 30, 2023 | -74.00 Mn |
| Jun 30, 2023 | 43.00 Mn |
| Mar 31, 2023 | 22.00 Mn |
| Dec 31, 2022 | 30.00 Mn |
| Sep 30, 2022 | -53.00 Mn |
| Jun 30, 2022 | 25.00 Mn |
| Mar 31, 2022 | -31.00 Mn |
| Dec 31, 2021 | 54.00 Mn |
| Sep 30, 2021 | 20.00 Mn |